Quality & Safety<strong>Australian</strong> Commissionon Safety <strong>and</strong> Qualityin Health Care –Medical DevicesIncidents WorkshopMeeting highlightsThe aim of this workshop, held on March29, <strong>2009</strong>, was to improve the sharing ofincident information nationally <strong>and</strong> tobetter underst<strong>and</strong> medical device safety,both in design <strong>and</strong> technical compliance<strong>and</strong> in the evaluation of the role ofhuman factors <strong>and</strong> training in minimisingincidents with medical devices. Participantsincluded government representativesof health services, clinicians, nurses,quality assurance managers <strong>and</strong> industryrepresentatives. Among the clinicians,anaesthetists were well represented.Need for better reportingThe keynote speaker was Dr Larry Kelly,head of Office of Devices, TherapeuticGoods Administration (TGA) who reportedon the TGA Medical Device IncidentReporting Investigation Scheme (IRIS).The role of TGA is to regulate <strong>and</strong> monitorthe supply <strong>and</strong> manufacturing controls ofmedical devices <strong>and</strong> drugs <strong>and</strong> to evaluateadverse events associated with the use ormisuse of a medical device. It is m<strong>and</strong>atoryfor a manufacturer to forward any detailsof reports it has received on a device thatdid or could have resulted in an adverseevent. TGA has considerable regulatoryauthority to investigate all such reports <strong>and</strong>if necessary to m<strong>and</strong>ate a recall. However,there is no such control on users as there isno obligation to report. Thus, an importantissue is the under-reporting of problemseither to TGA or the supplier.Dr Kelly presented figures for the 1317reports considered in 2008. Suppliersissued 1090 reports whereas hospitals,clinicians <strong>and</strong> nurses contributed only 190.The responses by TGA to the 1317 reportsreceived in 2008 indicated 20 recalls <strong>and</strong>30 alerts while improvement in design <strong>and</strong>user education were a major outcomein a further 160 instances.The take-home message was that thereis urgent need for better reporting by userseither through the suppliers or directlyto TGA.Need for better designs <strong>and</strong> systemsA biomedical approach to medical deviceincidents was presented by Mr PatrickO’Meley, Area Director, BiomedicalEngineering, Sydney South West AreaHealth. He believes that incidentmanagement is poorly managed withinadequate documentation <strong>and</strong> that currentpractices are not solving problems.While falls, drug errors <strong>and</strong> diagnosticerrors in hospitals are now welldocumented, reports on equipment failureare “buried”. There is an assumptionamongst users that modern devices aresafe, yet there is often a lack of experience,poor choice in selection <strong>and</strong> inadequateeducation or foresight. To date, the mainfocus has been on electrical safety <strong>and</strong>other factors overlooked are multiplicityof devices, a design which overlooks theusage environment, <strong>and</strong> the possibility offatal configuration or user mistakes thatare difficult to eliminate. Other problemsinclude outmoded st<strong>and</strong>ards, poor service<strong>and</strong> support, while human factors areoverwork, distraction, increased complexityof devices <strong>and</strong> overload of information.Mr O’Meley’s message was the need forbetter designs <strong>and</strong> systems along with thedevelopment of best practice guidelinesfor configuration <strong>and</strong> selection.Pump infusion errorsIn a paper on pump infusion errors,Dr John Lambert, F<strong>ANZCA</strong>, FJFICM,Director of Critical Care, Orange HospitalNSW suggested there was an increasingawareness that TGA approval is not the onlyrequirement for safe equipment choice asapproval may not meet reasonable clinicalst<strong>and</strong>ards or expectations.With regard to infusion pumps there isa wide variety of designs on offer withdramatically different form factors <strong>and</strong>user interfaces <strong>and</strong> many designs are notimmediately intuitive. In addition, thereis considerable variety in technologicalawareness by what is a relatively smallgroup of users, mainly nurses <strong>and</strong> doctors.Examples of the ability of clinicians to“innovate” at the bedside include the abilityto creatively bypass safety mechanisms<strong>and</strong> restrictions built into devices, thewillingness to use devices with nounderst<strong>and</strong>ing of how they work <strong>and</strong> theability to justify the purchase of expensiveequipment as m<strong>and</strong>atory with limitedevidence of the benefit of such equipment.In a search of international data for pumperrors using free text, the reports wereclassified as medication incidents, medicaldevices <strong>and</strong> clinical management. Theoutst<strong>and</strong>ing issue was pump setting errorswith less frequent reports of syringe/drug/fluid mix-up, errors in the use of infusiondevices or order error. Surprisingly, therewere free running line errors despitea “forcing function”. About 10-15% ofincidents involved the use of the wrongchannel on multi-channel devices, wrongpumps with multiple pumps in use <strong>and</strong> linemix-ups with lines swapped, mislabeled ornot tracked correctly.Of real concern was that the majority ofthese errors occurred in intensive care units.Suggestions for improvement includedavoidance of multi-channel devices,st<strong>and</strong>ardisation of devices to minimize userinterface difference errors, consideration ofthe use of unique devices for particularlydangerous infusions such as inotropes,epidurals, PCAs <strong>and</strong> possibly chemotherapy<strong>and</strong> the use of a forcing function for doublecheck when changing settings or lines.Case reportsOther case reports included the very fullinvestigation by Queensl<strong>and</strong> Health onadverse events with PICC lines (wherethe outcome of ongoing discussions withTGA <strong>and</strong> the manufacturers are pending),the safety of endoscopic vascular repairof aortic aneurysms <strong>and</strong> incidents withpleurocaths.Of particular interest was a presentationfrom Stella Robinson of South AustraliaHealth on hospital bed safety. Overseas datapresented indicated that bed entrapmentwas a significant cause of mortality in theelderly. A state-wide audit of hospital bedsin South Australia revealed that 84% ofbeds in that state presented a variety ofentrapment hazards, importantly includingundersized mattresses, presumablyintroduced for reasons of economy.We now await initiatives that may followthis workshop.Dr Patricia MackayVictoria46The <strong>ANZCA</strong> <strong>Bulletin</strong> <strong>June</strong> <strong>2009</strong>
Trauma, surgery,obstetrics <strong>and</strong> bleedingdisordersAnaesthetists <strong>and</strong> intensivists usuallyhave good access to blood <strong>and</strong> the bloodproducts they most commonly use <strong>and</strong> to aready source of advice from a haematologistor blood transfusion service whenuncommon issues arise.A previous article in the <strong>Bulletin</strong> (March<strong>2009</strong>) summarized the National BloodSupply Contingency Plan 2008. <strong>New</strong>lyreleased is information relevant to the careof patients known, or suspected to have ableeding disorder <strong>and</strong> who suffer trauma,require surgery or are pregnant.The technical information comes with theauthority of the National Blood Authority(NBA) Australia, the <strong>Australian</strong> BleedingDisorders Registry (ABDR), the <strong>Australian</strong>Haemophilia Centre Directors’ Organisation(AHCDO), the Haemophilia FoundationAustralia <strong>and</strong> all <strong>Australian</strong> governments.Websites include www.nba.gov.au; www.haemophilia.org.au <strong>and</strong> www.ahcdo.org.au.At this last website, under “publications”are “Surgery guidelines” <strong>and</strong> “Guidelinesfor the Management of Pregnancy”.Information provided by the ABDR includesa list of the different types of bleedingdisorders (36 in all), the usual “trigger” fordiagnosis (including trauma <strong>and</strong> surgery),the treatment regimen (on dem<strong>and</strong>,prophylaxis, tolerisation <strong>and</strong> secondaryprophylaxis) <strong>and</strong> the products available,including suppliers.Patient details registered with the ABDRwill be entered into a database aimed atproviding accurate information to theauthorities tasked with ensuring thatagents used for patient care are availablein Australia in quantities sufficient fordem<strong>and</strong>. This information is not currentlyaccurate, which is why the registry isbeing revitalized.While Fresh Frozen Plasma (FFP),cryoprecipitate, platelets, DDAVP <strong>and</strong>Tranexamic Acid are available generally,patients with specific bleeding disordersmust be registered on the ABDR inorder to be treated with the morespecialised products.As an aside, anyone wanting to use thisarticle as a stimulus for a CPD project couldinvestigate the latest information to befound on FFP, cryoprecipitate <strong>and</strong> plateletsthrough to more exotic products <strong>and</strong> theiruse for an increasing variety of bleedingdisorders, now including nine varieties ofvon Willebr<strong>and</strong>’s disease. Just a thought.Prof Garry PhillipsSouth AustraliaAudible oximeter tones<strong>and</strong> alarmsIn 2008 <strong>ANZCA</strong> revised ProfessionalSt<strong>and</strong>ard 18, Recommendations onMonitoring during Anaesthesia 1 . Thisst<strong>and</strong>ard now requires having an audiblevariable pulse tone from the oximeter. Italso requires an audible low limit alarm.“…the variable pulse tone as well as the lowthreshold alarm shall be appropriately set<strong>and</strong> audible to the practitioner responsiblefor the anaesthesia.”Correctly used monitoring tones <strong>and</strong> alarmspromote safety for our patients. Monitorsettings need to be checked at the beginningof a list <strong>and</strong> whenever there is a changeof anaesthetist. Inappropriate use ofmonitors puts patients at grave riskof undetected hypoxia.The US Anesthesia Patient SafetyFoundation has documented three casesof death <strong>and</strong> profound brain damagein healthy ASA1 patients due to lack ofappropriate monitoring 2 . These casesare recommended reading for allanaesthetists.Dr Rod TaylerEditorial Advisory BoardQuality <strong>and</strong> Safety Committee<strong>ANZCA</strong>1. www.anzca.edu.au/resources/professionaldocuments/professional-st<strong>and</strong>ards/ps18.html2. www.apsf.org/resource_center/newsletter/2004/winter/03turn_on.htmThe <strong>ANZCA</strong> <strong>Bulletin</strong> <strong>June</strong> <strong>2009</strong> 47